Paradigm Asset Management Co. LLC Sells 300 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Paradigm Asset Management Co. LLC reduced its stake in Roche Holding AG (OTCMKTS:RHHBY) by 6.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,351 shares of the company’s stock after selling 300 shares during the period. Paradigm Asset Management Co. LLC’s holdings in Roche were worth $152,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Kornitzer Capital Management Inc. KS raised its holdings in Roche by 1.3% in the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 136,923 shares of the company’s stock worth $5,490,000 after acquiring an additional 1,798 shares during the last quarter. Bard Financial Services Inc. raised its stake in shares of Roche by 37.7% in the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock worth $3,866,000 after purchasing an additional 30,350 shares during the last quarter. Diversified Trust Co raised its stake in shares of Roche by 1.2% in the fourth quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after purchasing an additional 711 shares during the last quarter. Hantz Financial Services Inc. lifted its holdings in shares of Roche by 0.9% during the fourth quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock valued at $1,176,000 after purchasing an additional 305 shares in the last quarter. Finally, Confluence Investment Management LLC boosted its position in shares of Roche by 26.3% during the fourth quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock valued at $488,000 after buying an additional 2,910 shares during the last quarter.

Roche Price Performance

Shares of OTCMKTS:RHHBY opened at $41.42 on Friday. The stock’s 50-day simple moving average is $37.57 and its two-hundred day simple moving average is $38.36. Roche Holding AG has a 52-week low of $29.20 and a 52-week high of $42.43. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on RHHBY shares. Sanford C. Bernstein raised Roche to a “strong-buy” rating in a research report on Thursday, January 30th. Morgan Stanley began coverage on shares of Roche in a report on Wednesday, February 12th. They set an “equal weight” rating for the company. Finally, UBS Group upgraded shares of Roche from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 13th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.